David Shima

Affiliated with

Research Area

Biography

David Shima has not added Biography.
If you are David Shima and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 25	2015

Other Publications

Article	Year
Sequential SNARE disassembly and GATE-16-GOS-28 complex assembly mediated by distinct NSF activities drives Golgi membrane fusion. The Journal of cell biology\| PubMed ID: 12070132	2002
VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. The EMBO journal\| PubMed ID: 12234928	2002
Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes & development\| PubMed ID: 12381667	2002
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (New York, N.Y.)\| PubMed ID: 12730604	2003
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. The Journal of cell biology\| PubMed ID: 12810700	2003
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. The Journal of experimental medicine\| PubMed ID: 12900522	2003
VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Investigative ophthalmology & visual science\| PubMed ID: 14744874	2004
Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Developmental dynamics : an official publication of the American Association of Anatomists\| PubMed ID: 15376331	2004
Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes & development\| PubMed ID: 15545635	2004
The role of vascular endothelial growth factor in ocular health and disease. Retina (Philadelphia, Pa.)\| PubMed ID: 15689799	2005
VEGF function in vascular pathogenesis. Experimental cell research\| PubMed ID: 16330026	2006
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16357200	2005
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature reviews. Drug discovery\| PubMed ID: 16518379	2006
Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. The American journal of pathology\| PubMed ID: 16723717	2006
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Molecular vision\| PubMed ID: 16735995	2006
An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17075074	2006
Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization. Molecular vision\| PubMed ID: 17110907	2006
Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Investigative ophthalmology & visual science\| PubMed ID: 17325165	2007
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Investigative ophthalmology & visual science\| PubMed ID: 17389510	2007
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. The American journal of pathology\| PubMed ID: 17591953	2007
Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. The Journal of biological chemistry\| PubMed ID: 17626017	2007
RGS5 expression is a quantitative measure of pericyte coverage of blood vessels. Angiogenesis\| PubMed ID: 18038251	2008
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization. Investigative ophthalmology & visual science\| PubMed ID: 18235012	2008
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors. Cancer research\| PubMed ID: 18381437	2008
Delta-like 4 is indispensable in thymic environment specific for T cell development. The Journal of experimental medicine\| PubMed ID: 18824583	2008
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study. Biochemical Society transactions\| PubMed ID: 19909247	2009
Delivery of anti-angiogenic molecular therapies for retinal disease. Drug discovery today\| PubMed ID: 20184967	2010
Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress photoreceptor cell fates of early retinal progenitors. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22323600	2012
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PloS one\| PubMed ID: 22567098	2012
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease. Investigative ophthalmology & visual science\| PubMed ID: 23385800	2013
VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. The American journal of pathology\| PubMed ID: 23416159	2013
A2E induces IL-1ß production in retinal pigment epithelial cells via the NLRP3 inflammasome. PloS one\| PubMed ID: 23840644	2013
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction. Investigative ophthalmology & visual science\| PubMed ID: 24845632	2014
Differential apicobasal VEGF signaling at vascular blood-neural barriers. Developmental cell\| PubMed ID: 25175707	2014